Condition: Immune Thrombocytopenia · Sponsor: Gliknik Inc.
The goal of this clinical trial is to demonstrate GL-2045 safety and efficacy proof of concept by demonstrating intravenous immunoglobulin (IVig)-like platelet responses in adult patients with Immune Thrombocytopenia (ITP).
This description comes directly from the study's public registry record.
Gliknik Clinical Trials Group · 410-665-0662 · gliknikclinicaltrialinquiries@gliknik.com
Always discuss trial participation with your own doctor first.
| Fortrea Clinical Research Unit Ltd | Leeds, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07605845